Trials / Conditions / Chronic Total Occlusion (CTO)

Chronic Total Occlusion (CTO)

14 registered clinical trials studyying Chronic Total Occlusion (CTO) — 7 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Chronic Total Occlusion and Triglyceride-Glucose Index NCT07451860	Kırıkkale University	—
Active Not Recruiting	AGECTO Study: PCI vs. Optimal Medical Therapy for CTO in the Octogenarian Patients NCT07442526	San Luigi Gonzaga Hospital	—
Recruiting	Clinical Outcomes of Drug-Coated Balloons in the Treatment of Patients With Coronary De Novo Chronic Total Occ NCT07463664	The First Affiliated Hospital of Zhengzhou University	N/A
Recruiting	FAPI Imaging Predicts Adverse Cardiac Events in Chronic Total Occlusion NCT07020858	Lin Zhao	—
Recruiting	Optimization of Complex Percutaneous Coronary Intervention With Liberal Use of Intracoronary Imaging Versus Co NCT07114393	Cathreine BV	—
Not Yet Recruiting	Feasibility of a Cardiac Rehabilitation Program for CTO Patients Before PCI Treatment NCT06610708	Luiz Ybarra	N/A
Recruiting	FAPI Imaging Assessment of Chronic Total Occlusion NCT06655922	Lin Zhao	—
Completed	Predictors and Long-term Incidence of In-stent Restenosis After Chronic Total Occlusion Percutaneous Coronary NCT07473596	Lauri Mansikkaniemi	N/A
Completed	A Prospective, Non-Randomized Pivotal Clinical Investigation to Demonstrate the Safety and Performance of the NCT06030271	Insight Lifetech Co., Ltd.	N/A
Completed	Remodeling of Distal Coronary Vessel in Chronic Total Occlusions: Prediction Based on Hemodynamic Coronary Par NCT06728384	Radboud University Medical Center	—
Active Not Recruiting	Coronary Laser in Undilatable or Uncrossable Lesions NCT07206082	Hospital Universitario La Paz	—
Recruiting	TRIO CTO (Taiwan Research Initiative on Coronary Total Occlusion) NCT06917378	National Taiwan University Hospital	—
Completed	A Novel Scoring System for Predicting the Success of PCI in Patients With CTO NCT06322914	The First Affiliated Hospital with Nanjing Medical University	—
Completed	EXPERT CTO: Evaluation of the XIENCE PRIME™ LL and XIENCE Nano™ Everolimus Eluting Coronary Stent Coronary Ste NCT01435031	Abbott Medical Devices	N/A